Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2007 1
2008 2
2011 2
2012 3
2016 1
2017 2
2018 1
2019 3
2020 2
2021 4
2022 8
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
Mitapivat versus Placebo for Pyruvate Kinase Deficiency.
Al-Samkari H, Galactéros F, Glenthøj A, Rothman JA, Andres O, Grace RF, Morado-Arias M, Layton DM, Onodera K, Verhovsek M, Barcellini W, Chonat S, Judge MP, Zagadailov E, Xu R, Hawkins P, Beynon V, Gheuens S, van Beers EJ; ACTIVATE Investigators. Al-Samkari H, et al. Among authors: beynon v. N Engl J Med. 2022 Apr 14;386(15):1432-1442. doi: 10.1056/NEJMoa2116634. N Engl J Med. 2022. PMID: 35417638 Clinical Trial.
The Impact of Bariatric Surgery on Nocturia Symptoms: a Systematic Review and Meta-Analysis.
Choi B, Ehsan A, Nakhoul M, Jegatheeswaran L, Yadav S, Panchaksharam D, Beynon V, Srivastava R, Baillie C, Stevens J, Bridgeman J, Moussa O, Irukulla S, Humadi S, Ratnasingham K. Choi B, et al. Among authors: beynon v. Obes Surg. 2022 Sep;32(9):3150-3155. doi: 10.1007/s11695-022-06215-5. Epub 2022 Jul 21. Obes Surg. 2022. PMID: 35864289 Review.
Mitapivat in adult patients with pyruvate kinase deficiency receiving regular transfusions (ACTIVATE-T): a multicentre, open-label, single-arm, phase 3 trial.
Glenthøj A, van Beers EJ, Al-Samkari H, Viprakasit V, Kuo KHM, Galactéros F, Chonat S, Porter J, Zagadailov E, Xu R, Oluyadi A, Hawkins P, Gheuens S, Beynon V, Barcellini W; ACTIVATE-T investigators. Glenthøj A, et al. Among authors: beynon v. Lancet Haematol. 2022 Oct;9(10):e724-e732. doi: 10.1016/S2352-3026(22)00214-9. Epub 2022 Aug 18. Lancet Haematol. 2022. PMID: 35988546 Clinical Trial.
microRNA-92a promotes CNS autoimmunity by modulating the regulatory and inflammatory T cell balance.
Fujiwara M, Raheja R, Garo LP, Ajay AK, Kadowaki-Saga R, Karandikar SH, Gabriely G, Krishnan R, Beynon V, Paul A, Patel A, Saxena S, Hu D, Healy BC, Chitnis T, Gandhi R, Weiner HL, Murugaiyan G. Fujiwara M, et al. Among authors: beynon v. J Clin Invest. 2022 May 16;132(10):e155693. doi: 10.1172/JCI155693. J Clin Invest. 2022. PMID: 35298438 Free PMC article.
28 results